Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients.

Díaz-Molina B, Diaz-Bulnes P, Carvajal Palao R, Bernardo MJ, Rodriguez RM, Corte-Iglesias V, Moris de la Tassa C, Lambert JL, Suarez-Alvarez B.

Front Immunol. 2018 Sep 26;9:2181. doi: 10.3389/fimmu.2018.02181. eCollection 2018.

2.

"Valve in valve" through femoral approach to allow the later implantation of long-term left ventricle assist device: a case report.

Pascual I, Díaz-Molina B, Lambert JL, Morales C, Henández-Vaquero D, Avanzas P, Díaz R, Alonso J, León V, Fernández-Suárez FE, Muñiz-Albaiceta G, Silva J, Morís C.

J Thorac Dis. 2018 Jun;10(6):E447-E449. doi: 10.21037/jtd.2018.05.132. No abstract available.

3.

Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy.

Gómez J, Lorca R, Reguero JR, Martín M, Morís C, Alonso B, Iglesias S, Díaz-Molina B, Avanzas P, Coto E.

Epigenomics. 2018 Jul;10(7):865-873. doi: 10.2217/epi-2017-0175. Epub 2018 Jul 2.

PMID:
29962225
4.

Prognostic Value of Serum Lactate Levels in Patients Undergoing Urgent Heart Transplant: A Subanalysis of the ASIS-TC Spanish Multicenter Study.

Couto-Mallón D, González-Vílchez F, Almenar-Bonet L, Díaz-Molina B, Segovia-Cubero J, González-Costello J, Delgado-Jiménez J, Castel-Lavilla MA, Crespo-Leiro MG, Rangel-Sousa D, Martínez-Sellés M, Rábago-Juan-Aracil G, De-la-Fuente-Galán L, Blasco-Peiró T, Hervás-Sotomayor D, Garrido-Bravo IP, Mirabet-Pérez S, Muñiz J, Barge-Caballero E.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):208-214. doi: 10.1016/j.rec.2018.02.021. Epub 2018 May 30. English, Spanish.

PMID:
29859897
5.

More intensive CMV-infection in chronic heart failure patients contributes to higher T-lymphocyte differentiation degree.

Moro-García MA, López-Iglesias F, Marcos-Fernández R, Bueno-García E, Díaz-Molina B, Lambert JL, Suárez-García FM, Morís de la Tassa C, Alonso-Arias R.

Clin Immunol. 2018 Jul;192:20-29. doi: 10.1016/j.clim.2018.03.015. Epub 2018 Mar 30.

PMID:
29608971
6.

Preoperative Toxoplasma gondii serostatus does not affect long-term survival of cardiac transplant recipients. Analysis of the Spanish Heart Transplantation Registry.

Barge-Caballero E, Almenar-Bonet L, Crespo-Leiro MG, Brossa-Loidi V, Rangel-Sousa D, Gómez-Bueno M, Farrero-Torres M, Díaz-Molina B, Delgado-Jiménez J, Martínez-Sellés M, López-Granados A, De-la-Fuente-Galán L, González-Costello J, Garrido-Bravo IP, Blasco-Peiró T, Rábago-Juan-Aracil G, González-Vílchez F.

Int J Cardiol. 2018 Jan 1;250:183-187. doi: 10.1016/j.ijcard.2017.09.215. Epub 2017 Oct 7.

PMID:
29031991
7.

Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.

González-Vílchez F, Lambert JL, Rangel D, Almenar L, de la Fuente JL, Palomo J, Díaz Molina B, Lage E, Sánchez Lázaro I, Vázquez de Prada JA.

Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):18-25. doi: 10.1016/j.rec.2017.03.014. Epub 2017 May 23. English, Spanish.

PMID:
28545984
8.

Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients.

Gómez J, Lorca R, Reguero JR, Morís C, Martín M, Tranche S, Alonso B, Iglesias S, Alvarez V, Díaz-Molina B, Avanzas P, Coto E.

Circ Cardiovasc Genet. 2017 Apr;10(2). pii: e001584. doi: 10.1161/CIRCGENETICS.116.001584.

PMID:
28356264
9.

Quality of Life According to Urgency Status in De Novo Heart Transplant Recipients.

Díaz-Molina B, Lambert JL, Vílchez FG, Cadenas F, Bernardo MJ, Velasco E, Martín M, Morís C.

Transplant Proc. 2016 Nov;48(9):3024-3026. doi: 10.1016/j.transproceed.2016.09.011.

PMID:
27932137
10.

Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

Sionis A; SEC Working Group for the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure:, Sionis Green A, Manito Lorite N, Bueno H, Coca Payeras A, Díaz Molina B, González Juanatey JR, Ruilope Urioste LM, Zamorano Gómez JL; Expert Reviewers for the 2016 ESC Guidelines for the Treatment of Acute and Chronic Heart Failure:, Almenar Bonet L, Ariza Solé A, Bover Freire R, Lambert Rodríguez JL, López de Sá E, López Fernández S, Martín Asenjo R, Mirabet Pérez S, Pascual Figal D, Segovia Cubero J, Varela Román A; SEC Guidelines Committee:, San Román Calvar JA, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marin Ortuño F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis Green A, Vázquez García R.

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1119-1125. doi: 10.1016/j.rec.2016.10.015. English, Spanish. No abstract available.

PMID:
27894486
11.

Atypical Atrial Flutter and Ablation of Recipient-to-Donor Atrioatrial Conduction After Orthotopic Heart Transplant.

Pérez Díez D, Calvo Cuervo D, Rubín JM, Díaz Molina B, Lambert JL, Morís de la Tassa C.

Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1114-1115. doi: 10.1016/j.rec.2016.06.005. Epub 2016 Aug 17. English, Spanish. No abstract available.

PMID:
27544239
12.

Left ventricle non-compaction: The still misdiagnosed cardiomyopathy.

Lorca R, Martín M, Reguero JJ, Díaz-Molina B, Morís C, Lambert JL, Astudillo A.

Int J Cardiol. 2016 Nov 15;223:420-421. doi: 10.1016/j.ijcard.2016.08.200. Epub 2016 Aug 12. No abstract available.

PMID:
27544597
13.

Effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients.

Díaz Molina B, Velasco Alonso E, Lambert Rodríguez JL, Rodríguez Bernardo MJ, Rozado Castaño J, Padrón Encalada R, Martín Fernández M, Pun Chinchai F, Colunga Blanco S, García Campos A.

Transplant Proc. 2015 Jan-Feb;47(1):130-1. doi: 10.1016/j.transproceed.2014.11.026.

PMID:
25645790
14.

Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry.

Martinez-Selles M, Almenar L, Paniagua-Martin MJ, Segovia J, Delgado JF, Arizón JM, Ayesta A, Lage E, Brossa V, Manito N, Pérez-Villa F, Diaz-Molina B, Rábago G, Blasco-Peiró T, De La Fuente Galán L, Pascual-Figal D, Gonzalez-Vilchez F; Spanish Registry of Heart Transplantation.

Transpl Int. 2015 Mar;28(3):305-13. doi: 10.1111/tri.12488. Epub 2014 Nov 27.

15.

The falling incidence of hematologic cancer after heart transplantation.

Crespo-Leiro MG, Delgado-Jiménez J, López L, Alonso-Pulpón L, González-Vilchez F, Almenar-Bonet L, Rábago G, Pérez-Villa F, Paniagua Martín MJ, Arizón Del Prado JM, Sousa-Casasnovas I, Manito-Lorite N, Díaz-Molina B, Pascual-Figal D, Lage-Galle E, Blasco-Peiró T, De la Fuente-Galán L, Muñiz J.

Clin Transplant. 2014 Oct;28(10):1142-7. doi: 10.1111/ctr.12432. Epub 2014 Oct 1.

PMID:
25100534
16.

Immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease.

Moro-García MA, Echeverría A, Galán-Artímez MC, Suárez-García FM, Solano-Jaurrieta JJ, Avanzas-Fernández P, Díaz-Molina B, Lambert JL, López-Larrea C, Morís de la Tassa C, Alonso-Arias R.

Int J Cardiol. 2014 Jul 1;174(3):590-9. doi: 10.1016/j.ijcard.2014.04.128. Epub 2014 Apr 21.

PMID:
24801091
17.

Update on heart failure, heart transplant, congenital heart disease, and clinical cardiology.

Almenar L, Zunzunegui JL, Barón G, Carrasco JI, Gómez-Doblas JJ, Comín J, Barrios V, Subirana MT, Díaz-Molina B.

Rev Esp Cardiol (Engl Ed). 2013 Apr;66(4):290-7. doi: 10.1016/j.rec.2012.10.018. Epub 2013 Jan 12. Review.

PMID:
24775619
18.

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?

Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T.

Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23.

PMID:
24309084
19.

Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.

González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M.

Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241. Epub 2013 Sep 12.

PMID:
24025040
20.

Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation.

Díaz-Molina B, Tavira B, Lambert JL, Bernardo MJ, Alvarez V, Coto E.

Transplant Proc. 2012 Nov;44(9):2635-8. doi: 10.1016/j.transproceed.2012.09.062.

PMID:
23146479

Supplemental Content

Loading ...
Support Center